GSK says tests indicate antibody drug works against Omicron
By Ludwig Burger 5 hrs ago
(Reuters) -Laboratory analysis of the antibody-based COVID-19 therapy GlaxoSmithKline (GSK) is developing with U.S. partner Vir has indicated the drug is effective against the new Omicron variant, the British drugmaker said on Thursday.